Colorectal hepatic metastases: Detection with SPIO-enhanced breath-hold MR imaging - Comparison of optimized sequences

Radiology

Volumn 228, Issue 3, 2003, Pages 709-718

  Ward, Janice ^a   Guthrie, J Ashley ^a   Wilson, Daniel ^a   Arnold, Paul ^a   Lodge, J Peter ^a   Toogood, Giles J ^a   Wyatt, Judith I ^a   Robinson, Philip J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Iron; Liver neoplasms, metastases; Liver neoplasms, MR; Magnetic resonance (MR), comparative studies, Magnetic resonance (MR) contrast enhancement; Magnetic resonance (MR), contrast media

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CLINICAL OBSERVATION; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTRON SPIN RESONANCE; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; PROCESS OPTIMIZATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; STUDENT T TEST;

COLORECTAL NEOPLASMS; CONTRAST MEDIA; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FERRIC COMPOUNDS; HUMANS; IMAGE ENHANCEMENT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0042932352     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2283020376     Document Type: Article

References (24)

1. Bellin MF, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994; 193:657-663.
2. Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995; 196:471-478.
3. Ros PR, Freeny PC, Harms S, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196:481-488.
4. Senéterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200:785-792.
5. Blakeborough A, Ward J, Wilson D, et al. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 1997; 203:759-765.
6. Muller RD, Vogel K, Neumann K, et al. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver. Acta Radiol 1999; 40:628-635.
7. Poeckler-Schoeniger C, Koepke J, Gueckel F, Sturm J, Georgi M. MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesions. Magn Reson Imaging 1999; 17:383-392.
8. Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999; 210:459-466.
9. Reimer P, Jähnke N, Fiebich M, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000; 217:152-158.
10. Ward J, Chen F, Guthrie JA, et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 2000; 214:159-166.
11. Abe Y, Yamashita Y, Namimoto T, Tang Y, Takahashi M. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequences. Radiat Med 2000; 18:97-105.
12. Scott J, Ward J, Guthrie JA, Wilson D, Robinson PJ. MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases. Magn Reson Imaging 2000; 18:297-303.
13. McNeil BJ, Hanley JA. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med Decis Making 1984; 4:137-150.
14. Ba-Ssalamah A, Heinz-Peer G, Schima W, et al. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000; 11:665-672.
15. Schwartz LH, Seltzer SE, Tempany CM, et al. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences. J Magn Reson Imaging 1995; 5:566-570.
16. Ernst R, Anderson WA. Application for Fourier transform spectroscopy to magnetic resonance. Rev Sci Instr 1966; 37:93-102.
17. Goldberg MA, Hahn PF, Saini S, et al. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR Am J Roentgenol 1993; 160:1011-1017.
18. Thickman D, Hendrick RE, Jerjian KA, Schanker CS. Liver-lesion tissue contrast on MR images: effect of iron oxide concentration and magnetic field strength. Radiology 1990; 176:557-562.
19. Scott DJ, Ward J, Guthrie JA, Wilson D, Robinson PJ. The impact of reduced dose SPIO on the detection of colorectal liver metastases: a quantitative and qualitative analysis (abstr). In: Proceedings of the Eighth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2000; 207.
20. Van Beers BE, Lacrosse M, Jamart J, et al. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging. AJR Am J Roentgenol 1997; 168:713-717.
21. Fretz CJ, Stark DD, Metz CE, et al. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging and iron oxide enhanced MR imaging. AJR Am J Roentgenol 1990; 155:763-770.
22. Semelka RC, Lee JK, Worawattanakul S, Noone TC, Patt RH, Ascher SM. Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI. J Magn Rseon Imaging 1998; 8:670-674.
23. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000; 216:154-162.
24. Ward J, Robinson PJ. Combined use of MR contrast agents for evaluating liver disease. Magn Reson Imaging Clin N Am 2001; 9:767-783.